Pharmaceutical News and Articles

Public Believes Dermatologic Side Effects From Cancer Treatment Are Common

Most individuals living in underserved communities believe that dermatologic side effects (DSEs) from anticancer therapies (ACTs) occur at high rates, according

GLP-1 Receptor Agonists May Reduce Complications of Diabetic Retinopathy

For individuals with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a slightly increased risk for incident di

440 Deaths in Los Angeles County Reported Due to January 2025 Wildfires

An estimated 440 deaths from Jan. 5 to Feb. 1, 2025, in Los Angeles County were attributable to the Los Angeles wildfires, according to a research letter publis

Harmonic-to-Noise Ratio Could Identify Early Laryngeal Cancer

Acoustic features, specifically harmonic-to-noise ratio (HNR) and its variability, could be promising for early detection of vocal fold lesions, according to a

FDA Approves Brinsupri (brensocatib) for the Treatment of Non-Cystic Fibrosis Bronchiectasis

AI Might Be Able To Ease ER Overcrowding And Boarding

TUESDAY, Aug. 12, 2025 Artificial intelligence (AI) programs can help doctors and nurses predict hours earlier which ER patients will likely require hospital ad

High Blood Pressure? Try An Indoor Air Purifier

TUESDAY, Aug. 12, 2025 Folks fighting high blood pressure might receive some help from a household air purifier, a new study says.Even in areas with relatively

Drivers Of Childhood Asthma More Complex Than Thought

TUESDAY, Aug. 12, 2025 Asthma flare-ups in children might be more complicated than previously thought, with hidden forces combining to restrict their airways, a

Update: NYC Legionnaires’ Outbreak Grows to 90 Cases; 3 Deaths Reported

TUESDAY, Aug. 12, 2025 A Legionnaires disease outbreak in Central Harlem has now sickened 90 people and caused three deaths, New York City health officials said

Biogen and Stoke Therapeutics Announce First Patient Dosed in Phase 3 EMPEROR Study of Zorevunersen, a Potential Disease-Modifying Treatment for Dravet Syndrome

Biogen Inc. (Nasdaq BIIB) and Stoke Therapeutics, Inc. (Nasdaq STOK), a biotechnology company dedicated to restoring protein expression by harnessing the body s